PFG Private Wealth Management’s Novartis NVS Stock Holding History

PFG Private Wealth Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-100	Closed	-$9.67K	–	246
2024 Q1	$9.67K	Hold	100	–	–	0.01%	135
2023 Q4	$10.1K	Hold	100	–	–	0.01%	138
2023 Q3	$10.2K	Hold	100	–	–	0.01%	189
2023 Q2	$10.1K	Hold	100	–	–	0.01%	211
2023 Q1	$9.2K	Sell	100 -29	-22%	-$2.53K	0.01%	208
2022 Q4	$12K	Buy	129 +29	+29%	+$2.44K	0.01%	180
2022 Q3	$8K	Hold	100	–	–	0.01%	195
2022 Q2	$8K	Hold	100	–	–	﹤0.01%	205
2022 Q1	$9K	Hold	100	–	–	﹤0.01%	208
2021 Q4	$9K	Hold	100	–	–	﹤0.01%	206
2021 Q3	$8K	Buy	+100	New	+$9K	﹤0.01%	202

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CCM

Cullen Capital Management New York $9.75B AUM 21.81% 1-Year Est. Return

PFG Private Wealth Management's NVS Position: Q2 2024 in Review

PFG Private Wealth Management sold out of Novartis (NVS) in Q2 2024, closing a stake of 100 shares — an estimated $9.67K sold.

PFG Private Wealth Management first reported a position in NVS in Q3 2021 and held it in 11 quarters. The position peaked at $12K in Q4 2022. 1,306 funds tracked by Wall St. Rank hold NVS as of Q2 2024.

PFG Private Wealth Management reported no remaining Novartis position as of Q2 2024 after selling out during the quarter.
PFG Private Wealth Management sold 100 Novartis shares in Q2 2024, an estimated $9.67K.
PFG Private Wealth Management first reported a position in Novartis in Q3 2021 and held it in 11 quarters.
PFG Private Wealth Management's Novartis position peaked at $12K in Q4 2022.
1,306 funds tracked by Wall St. Rank held Novartis as of Q2 2024.

Based on PFG Private Wealth Management's 13F filing for Q2 2024, filed 15 Jul 2024.